Aspenberg P, HK Genant, T Johansson, AJ Nina, K See, K Krohn, PA Garcia-Hernandez, CP Recknor, TA Einhorn, GP Dalsky, BC Mitlak, A Fierlinger, MC Lakshmanan.
Periparatide for acceleration of fracture repair in humans: A prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures.
J Bone Min Res 2010, 25(2): 404-414.

Barascuk N, H Skjøt-Arkil, TC Register, L Larsen, I Byrjalsen, C Christiansen, MA Karsdal.
Human macrophage foam cells degrade artherosclerotic plaques though cathepsin K mediated processes.
BCM Cardivascular Disorders  2010; 10:19.

Barascuk N, SS Veidal, L Larsen, DV Larsen,  MR Larsen, J Wang, Q Zheng, R Xing, Y Cao, LM Rasmussen, MA Kardal.
A Novel assay for extracellular matrix remodeling associated with liver fibrosis: An enzyme-linked immunosorbent assay (ELISA) for a MMP-proteolytically revealed neo-epitope of Type III collagen.
Clin Biochem 2010; 43(10-11): 899-904.

Bay –Jensen AC, BC Søndergaard, C Christiansen, MA Karsdal, SH Madsen, P. Qvist.
Biochemical markers of joint tissue turnover.
Assay Drug Dev Technol  2010; 8(1): 118-124.

Bay- Jensen AC, S Hoegh-Madsen, E Dam, K Henriksen, BC Søndergaard, P Pastoureau, P Qvist, MA Karsdal.
Which elements are involved in reversible and irreversible cartilage degradation in osteoarthritis?
Rheumatology Int 2010;30(4):435-442.

Black DM, MP Kelly, HK Genant, L Palermo, R Eastell, C Bucci-Rechtweg, J Cauley, PC Leung, S Boonen, A Santora, A de Papp, DC Bauer.
Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.
N Engl J Med 2010, 10.1056/NEJMoa. 1001086.

Christiansen C, CH Chesnut III, JD Adachi, JP Brown, CE Fernandes, AWC Lung, S Palacios, AB Levine, AA Chines, GD Constantine.
Safety of bazedoxifene in a randomized, bouble-blind, placebo- and active controlled phase 3 study of postmenopausal women with osteoporosis.
BMC Musculoskeletal Disorders, 2010;11: 130.

Embree MC, TM Kilts, M Ono, CA Inkson, F Syed-Picard, MA Karsdal, A Oldberg, Y Bi, MF Young.
Biglycan and fibromodulin have essential roles in regulating chondrogenesis and extracellular matrix turnover in temporomandibular joint osteoarthritis.
Am J Pathol  2010;176(2):812-826.

 Fogari R, S Taddei, M Holm-Bentzen, J Baszak, L Melani, K Schumacher.
Efficacy and safety of Olmesartan medoxomil 40 mg/hydrochlorothiazide 12.5 mg Combination therapy versus Olmesartan medoxomil 40 mg monotherapy in patients with
Moderate to severe hypertension.
Clin Drug Investi 2010; 581-597.

Gooi JH, S Pompolo, MA Karsdal, NH Kulkarni, I Kalajzic SH McAhren, B Han, JE Onyia, PW Ho, MT Gillespie, NC Walsch, LY Chia, JM Quinn, TJ Martin, NA Sims.
Calcitonin impairs the anabolic effect of PTH in young rats and stimulates expression of sclerostin by osteocytes.
Bone, 2010; 46(6): 1486-1497.

Henriksen K, KM Bohren,  AC Bay-Jensen, MA Karsdal.
Should biochemical markers of bone turnover be considered standard practise for safety pharmacology?
Biomarkers  2010 15(3): 195-204.

Henriksen K, J Bollerslev, V Everts, MA Karsdal.
Osteoclast activity and subtypes as a function of physiology and pathology- Implications for future treatments of osteoporosis.
Endocrine Revievs 2010; 10.1210/er.2010-0006.

Henriksen K , AC Bay-Jensen, C Christiansen, MA Karsdal.
Oral Salmon calcitonin-pharmacology in osteoporosis.
Expert Opin Biol Ther, 2010 (11): 1617-1629.

Juhl CB, K Højlund, R Elsborg, MK Poulsen, PE Selmar, JJ Holst, Claus Christiansen, H Beck-Nielsen.
Automated detection of hypoglycaemia-induced EEG changes recorded by subcutaneous electrodes in subjects with type I diabetes- The brain as a biosensor.
Diabetes Res Clin Pract 2010; 88(1): 22-28.

Karsda MA, I Byrjalsen, K Henriksen, BJ Riis, C  Christiansen.
Investigations of inter-and intra-individual relationships between exposure to oral salmon calcitonin and a surrogate marker of pharmacodynamic efficacy.
Eur J Clin Pharmacol 2010;66(1): 29-37.

Karsdal MA, I Byrjalsen, K Henriksen, A-C Bay-Jensen, C Christiansen, BJ Riis,
The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14 day randomized study.
Osteoarthr & Cartilage  2010; 18(2): 150-159.

Karsdal MA, K Henriksen, AC Bay-Jensen, B Molloy, M Arnold, MR John, I Byrjalsen, M Azria, BJ Riis, P Qvist, C Christiansen.
Lessons learned from the development of oral calcitonin. The first tablet formulation of a peptide in Phase III Clinical trials.
J Clin Pharmacol 10.1177.august 2010.
 
 Karsdal MA, I Byrjalsen, AC Bay-Jensen, K Henriksen, BJ Riis, C Christiansen.
Biochemical markers identify influences on bone and cartilage degradation in osteoarthritis- the effect of sex, Kellgren-Lawrence (KL) score, Body Mass Index (BMI), oral salmon calcitonin (sCT) treatment and diurnal variation.
BMC Musculoskeletal Disord 2010; 11: 125.

Karsdal MA, K Henriksen, DJ Leeming, T Woodworth, E Vassiliadis, AC Bay-Jensen.
Novel combinations of post-translational modification (PTM) neo-epitopes provide tissue specific biochemical markers- are they the cause or the consequence of the disease?
Clin Biochem 2010; 43: 793-804.

Leeming DJ.
A sensitive biomarker for the detection of bone metastases.
Clin Lab Int 2010;1: 22-23.  

Leeming DJ, DV Larsen, C Zhang, Y He, SS Veidal, RH Nielsen, K Henriksen, Q Zheng, V Barkholt, BJ Riis, I Byrjalsen, P Qvist, MA Karsdal.
Enzyme-linked immunosorbent serum assays (ELISAs) for rat and human N-terminal pro-peptide of collagen type I (PINP)- assessment of corresponding epitopes.
Clinical Biochemistry  2010; 43: 1249-1256.

Leeming DJ, M Koizumi, P Qvist, V Barkholt, C Zhang, K Henriksen, I Byrjalsen, MA Karsdal.
Serum N-terminal propeptide of collagen type I is associated with the number of bone metastases in breast and prostate cancer and correlates to other bone related markers.
Biomarker Insights 2010;2: 1-9.

Lillemark L, M Ganz, N Barascuk, EB Dam, M Nielsen.
Growth patterns of abdominal atherosclerotic calcified deposits from lumbar lateral X-rays.
Int J Cardiovasc Imaging  2010 (26(7): 751-761.

Madsen SH, EU Sumer, AC Bay-Jensen, BC Søndergaard, P Qvist, MA Karsdal.
Aggrecanase and MMP-mediated aggrecan degradation is associated with different molecular characteristics of aggrecan and separated in time ex vivo.
Biomarkers 2010; 15(3): 266-276.

Nielsen M, PC Pettersen, P Alexandersen, G Karemore, J Raundahl, M Loog, C Christiansen.
Breast density changes associated with postmenopausal hormone replacement therapy: post hoc radiologist- and computer-based analyses.
Menopause 17(4): 772-778.

Nielsen M, M Ganz, F Lauze, PC Pettersen, M De Bruijne, TB Clarkson, EB Dam, C Christiansen, MA Karsdal.
Distribution, size, shape, growth potential and extent of abdominal aortic calcified deposits predict mortality in postmenopausal women.
BMC  Cardiovascular Disorders 2010, 10:56.

Neutzsky-Wulff AV, MG Sørensen, D Kocijancic, DJ Leeming,  MH Dziegiel, MA Karsdal, K Henriksen.
Alterations in osteoclast function and phenotype induced by different inhibitors of bone resorption- Implications for osteoclast quality.
BMC Musculoskeletal Disord 2010; 11: 109.
 
Neutzsky-Wulff AV, N A Sims, C Supanchart,  U Kornak, D. Felsenberg,IJ Poulton, TJ Martin, MA Karsdal, K Henriksen.
Severe developmental bone phenotype in CIC-7 deficient mice.
Dev Biol 2010; 344(2): 1001-1010.

Qazi AA, DR Jørgensen, M Lillholm, M Loog, M Nielsen, EB Dam.
A framework for optimizing the measurement weight maps to minimize the required sample size .
Med Image Anal 2010;14(3): 255-264.

Qvist P, C Christiansen, MA Karsdal, SH Madsen, BC Søndergaard, AC Bay-Jensen.
Application of biochemical markers in development of drugs for treatment of osteoarthritis.
Biomarkers 2010; 15(1): 1-19.

Shane E.
Evolving data about subtrochanteric fractures and bisphosphonates.
Editorial.
N Engl J Med 2010, 10.1056/Nej Me 1003064.

Schultz P, J Werner, T Stauber, K Henriksen, K Fendler.
The G215R mutation in the C1/H- antiporter CIC-7 found in ADOII osteoporosis does not abolish function but causes a severe trafficking defect.
PlosOne 2010, 5(9): e12585.

Skjøt-Arkil H, N Barascuk, T Register, MA Karsdal.
Macrophage-mediated proteolytic remodeling of the extracellular matrix in arthrosclerosis results in neoepitopes: a potential new class of biochemical markers.
ASSAY and Drug Development Technologies 2010;8(5): 542-552.

Søndergaard BC, N Schultz, SH Madsen, AC Bay-Jensen, M Kassem, MA Karsdal.
MAPKs are essential upstream signalling pathways in proteolytic cartilage degradation-
divergence in pathways leading to aggrecanase and MMP mediated articular degradation.
Osteoarthritis Cartilage 2010; 18(3): 279-288.

Søndergaard BC, S H Madsen, T Segovia-Silvestre,  SJ Paulsen,C Pedersen, AC Bay-Jensen , MA Karsdal.
Investigation of the direct effect of salmon calcitonin on human osteoarthritic chondrocytes.
BMC Musculoskeletal Disord 2010; 11:62.

Sørensen MG, MA Karsdal, MH Dziegiel, JA Boutin, O Nosjean, K Henriksen.
Screening of protein kinase inhibitors identifies PKC inhibitors as inhibitors of osteoclastic acid secretion and bone resorption.
BMC  Musculoskelet Disord 2010; 11(1): 250.

Veidal SS, AC Bay-Nielsen, G Tougas, MA Karsdal, B Vainer.
Serum markers of liver fibrosis: Combining the BIPED classification and the neo-epitope approach in the development of new biomarkers.
Dis Markers 2010; 28(1): 15-28.

Veidal SS, E Vassiliadis, AC Bay-Jensen, G Tougas, Vainer B, MA Karsdal.
Prollagen type N-terminal propeptide (PINP) a marker for fibrogenesis in Bile Duct Ligation-induced fibrosis in rats.
Fibrogenesis and Tissue Repair 2010; 3(1):5.

Veidal SS, E Vassiliadis, N Barascuk, C Zhang, T Segovia-Silvestre, L Klickstein, MR Larsen, P Qvist, C Christiansen, B Vainer, MA Karsdal.
MMP-9 mediated type III collagen degradation as a novel serological biochemical markers for liver fibrogenesis.
Liver International 2010; 1293-1304.